Sodium in PDB 6yb6: Thrombin in Complex with D-Phe-Pro-3-Chloro-1,3-Dihydroxybenzylamide Derivative (13C)
Enzymatic activity of Thrombin in Complex with D-Phe-Pro-3-Chloro-1,3-Dihydroxybenzylamide Derivative (13C)
All present enzymatic activity of Thrombin in Complex with D-Phe-Pro-3-Chloro-1,3-Dihydroxybenzylamide Derivative (13C):
3.4.21.5;
Protein crystallography data
The structure of Thrombin in Complex with D-Phe-Pro-3-Chloro-1,3-Dihydroxybenzylamide Derivative (13C), PDB code: 6yb6
was solved by
A.Sandner,
A.Heine,
G.Klebe,
N.Abazi,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
35.59 /
1.33
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
70.436,
71.2,
72.316,
90,
100.2,
90
|
R / Rfree (%)
|
13.1 /
15.3
|
Other elements in 6yb6:
The structure of Thrombin in Complex with D-Phe-Pro-3-Chloro-1,3-Dihydroxybenzylamide Derivative (13C) also contains other interesting chemical elements:
Sodium Binding Sites:
The binding sites of Sodium atom in the Thrombin in Complex with D-Phe-Pro-3-Chloro-1,3-Dihydroxybenzylamide Derivative (13C)
(pdb code 6yb6). This binding sites where shown within
5.0 Angstroms radius around Sodium atom.
In total 2 binding sites of Sodium where determined in the
Thrombin in Complex with D-Phe-Pro-3-Chloro-1,3-Dihydroxybenzylamide Derivative (13C), PDB code: 6yb6:
Jump to Sodium binding site number:
1;
2;
Sodium binding site 1 out
of 2 in 6yb6
Go back to
Sodium Binding Sites List in 6yb6
Sodium binding site 1 out
of 2 in the Thrombin in Complex with D-Phe-Pro-3-Chloro-1,3-Dihydroxybenzylamide Derivative (13C)
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 1 of Thrombin in Complex with D-Phe-Pro-3-Chloro-1,3-Dihydroxybenzylamide Derivative (13C) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
H:Na301
b:16.2
occ:1.00
|
O
|
H:LYS169
|
2.3
|
13.9
|
0.3
|
O
|
H:THR172
|
2.4
|
15.6
|
1.0
|
O
|
H:LYS169
|
2.4
|
14.4
|
0.7
|
O
|
H:HOH527
|
2.4
|
27.8
|
1.0
|
O
|
H:HOH469
|
3.0
|
25.9
|
1.0
|
HA
|
H:ASP170
|
3.3
|
16.4
|
1.0
|
HG2
|
H:LYS169
|
3.4
|
20.8
|
0.3
|
C
|
H:LYS169
|
3.5
|
13.6
|
0.3
|
C
|
H:LYS169
|
3.5
|
13.8
|
0.7
|
HG2
|
H:LYS169
|
3.5
|
24.3
|
0.7
|
H
|
H:THR172
|
3.5
|
16.4
|
1.0
|
C
|
H:THR172
|
3.6
|
14.3
|
1.0
|
HA
|
H:ARG173
|
3.7
|
17.9
|
1.0
|
HZ3
|
H:LYS169
|
3.7
|
32.4
|
0.7
|
CA
|
H:ASP170
|
4.0
|
13.7
|
1.0
|
N
|
H:ASP170
|
4.1
|
13.4
|
1.0
|
CG
|
H:LYS169
|
4.3
|
17.3
|
0.3
|
N
|
H:THR172
|
4.3
|
13.7
|
1.0
|
CG
|
H:LYS169
|
4.3
|
20.2
|
0.7
|
HG3
|
H:LYS169
|
4.3
|
24.3
|
0.7
|
HG3
|
H:LYS169
|
4.3
|
20.8
|
0.3
|
C
|
H:ASP170
|
4.4
|
14.0
|
1.0
|
N
|
H:ARG173
|
4.4
|
14.4
|
1.0
|
CA
|
H:ARG173
|
4.4
|
14.9
|
1.0
|
HA
|
H:LYS169
|
4.5
|
16.2
|
0.7
|
HA
|
H:LYS169
|
4.5
|
16.2
|
0.3
|
HG23
|
H:THR172
|
4.5
|
18.0
|
1.0
|
CA
|
H:LYS169
|
4.5
|
13.5
|
0.7
|
CA
|
H:LYS169
|
4.5
|
13.5
|
0.3
|
NZ
|
H:LYS169
|
4.5
|
27.0
|
0.7
|
CA
|
H:THR172
|
4.6
|
14.0
|
1.0
|
HE2
|
H:LYS169
|
4.6
|
24.6
|
0.3
|
OD1
|
H:ASP170
|
4.7
|
18.7
|
1.0
|
HZ2
|
H:LYS169
|
4.7
|
32.4
|
0.7
|
HG22
|
H:THR172
|
4.7
|
18.0
|
1.0
|
O
|
H:ASP170
|
4.8
|
14.7
|
1.0
|
N
|
H:SER171
|
4.8
|
13.2
|
1.0
|
H
|
H:SER171
|
4.9
|
15.8
|
1.0
|
CB
|
H:LYS169
|
4.9
|
16.7
|
0.7
|
CB
|
H:LYS169
|
4.9
|
15.4
|
0.3
|
HZ1
|
H:LYS169
|
4.9
|
32.4
|
0.7
|
H
|
H:ASP170
|
5.0
|
16.0
|
0.7
|
H
|
H:ASP170
|
5.0
|
16.0
|
0.3
|
|
Sodium binding site 2 out
of 2 in 6yb6
Go back to
Sodium Binding Sites List in 6yb6
Sodium binding site 2 out
of 2 in the Thrombin in Complex with D-Phe-Pro-3-Chloro-1,3-Dihydroxybenzylamide Derivative (13C)
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 2 of Thrombin in Complex with D-Phe-Pro-3-Chloro-1,3-Dihydroxybenzylamide Derivative (13C) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
H:Na302
b:16.7
occ:1.00
|
O
|
H:ARG221A
|
2.3
|
18.3
|
1.0
|
O
|
H:HOH560
|
2.3
|
17.5
|
1.0
|
O
|
H:HOH481
|
2.4
|
17.9
|
1.0
|
O
|
H:LYS224
|
2.4
|
15.4
|
0.6
|
O
|
H:LYS224
|
2.4
|
15.5
|
0.4
|
O
|
H:HOH489
|
2.4
|
14.4
|
1.0
|
O
|
H:HOH499
|
2.7
|
19.1
|
1.0
|
H
|
H:LYS224
|
3.2
|
19.0
|
0.6
|
H
|
H:LYS224
|
3.3
|
19.4
|
0.4
|
C
|
H:ARG221A
|
3.4
|
18.7
|
1.0
|
C
|
H:LYS224
|
3.4
|
14.9
|
0.4
|
C
|
H:LYS224
|
3.4
|
14.6
|
0.6
|
HA
|
H:ASP221
|
3.7
|
22.3
|
1.0
|
HA
|
H:ASP222
|
3.7
|
24.8
|
1.0
|
HB2
|
H:LYS224
|
3.8
|
17.8
|
0.6
|
HB2
|
H:LYS224
|
3.8
|
19.3
|
0.4
|
N
|
H:ARG221A
|
3.9
|
19.1
|
1.0
|
N
|
H:LYS224
|
3.9
|
15.8
|
0.6
|
N
|
H:LYS224
|
3.9
|
16.2
|
0.4
|
H
|
H:ARG221A
|
3.9
|
23.0
|
1.0
|
O
|
H:HOH511
|
3.9
|
15.6
|
1.0
|
H
|
H:GLY223
|
4.0
|
22.0
|
1.0
|
O
|
H:HOH491
|
4.0
|
21.8
|
1.0
|
HA
|
H:TYR225
|
4.1
|
16.0
|
1.0
|
C
|
H:ASP221
|
4.1
|
19.1
|
1.0
|
O
|
H:TYR184A
|
4.1
|
16.1
|
1.0
|
CA
|
H:LYS224
|
4.1
|
15.7
|
0.4
|
CA
|
H:LYS224
|
4.2
|
15.0
|
0.6
|
N
|
H:ASP222
|
4.2
|
20.4
|
1.0
|
O
|
H:HOH502
|
4.2
|
15.8
|
1.0
|
CA
|
H:ARG221A
|
4.2
|
20.1
|
1.0
|
N
|
H:GLY223
|
4.3
|
18.4
|
1.0
|
CA
|
H:ASP222
|
4.3
|
20.6
|
1.0
|
CA
|
H:ASP221
|
4.4
|
18.6
|
1.0
|
N
|
H:TYR225
|
4.5
|
13.8
|
1.0
|
CB
|
H:LYS224
|
4.5
|
16.1
|
0.4
|
CB
|
H:LYS224
|
4.5
|
14.8
|
0.6
|
C
|
H:ASP222
|
4.5
|
19.6
|
1.0
|
O
|
H:ASP221
|
4.5
|
21.1
|
1.0
|
OD1
|
H:ASP221
|
4.6
|
18.5
|
1.0
|
CA
|
H:TYR225
|
4.7
|
13.3
|
1.0
|
O
|
H:HOH555
|
4.8
|
31.4
|
1.0
|
HB2
|
H:ARG221A
|
4.8
|
26.9
|
1.0
|
C
|
H:GLY223
|
4.9
|
16.2
|
1.0
|
HB3
|
H:LYS224
|
4.9
|
19.3
|
0.4
|
HA
|
H:ARG221A
|
4.9
|
24.1
|
1.0
|
H
|
H:ASP221
|
5.0
|
21.8
|
1.0
|
HA3
|
H:GLY184
|
5.0
|
15.1
|
1.0
|
H
|
H:ASP222
|
5.0
|
24.5
|
1.0
|
|
Reference:
A.Sandner,
A.Heine,
G.Klebe.
Thrombin in Complex with D-Phe-Pro-3-Chloro-1,3-Dihydroxybenzylamide Derivative (13C) To Be Published.
Page generated: Sat Apr 3 17:51:49 2021
|